You are here

Clinical Trials: Digestive System Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, August 30, 2022 - 12:00
Conditions:   Stenosis; Bowel;   Crohn Disease
Intervention:   Drug: Adipose derived allogenic mesenchymal stem cells (adAMSC)
Sponsors:   Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz;   Effice Servicios Para la Investigacion S.L.
Not yet recruiting
Posted: Friday, August 19, 2022 - 12:00
Condition:   Cirrhosis Due to Hepatitis B
Interventions:   Biological: UC-MSCs;   Biological: Saline solution
Sponsors:   Renmin Hospital of Wuhan University;   VCANBIO Cell & Gene Engineering Corporation, Ltd;   Wuhan Optics Valley Zhongyuan Pharmaceutical Co., Ltd., Hubei, China
Posted: Monday, August 8, 2022 - 12:00
Condition:   Acute Liver Failure
Intervention:   Biological: HMB002
Sponsors:   King's College Hospital NHS Trust;   Medical Research Council
Not yet recruiting
Posted: Tuesday, June 7, 2022 - 12:00
Condition:   Rectal Fistula
Interventions:   Biological: OSSM-001;   Other: Placebo
Sponsor:   Ossium Health, Inc.
Not yet recruiting
Posted: Thursday, June 2, 2022 - 12:00
Condition:   Fistula Perianal
Intervention:   Other: placenta-MSCs derived exosomes
Sponsor:   Tehran University of Medical Sciences
Posted: Thursday, March 24, 2022 - 12:00
Conditions:   Digestive System Diseases;   Inflammatory Bowel Disease, Ulcerative Colitis Type;   Crohn Disease
Intervention:   Procedure: additional biopsies
Sponsor:   Rennes University Hospital
Not yet recruiting
Posted: Wednesday, March 2, 2022 - 12:00
Condition:   Crohn Disease
Intervention:   Biological: Human Umbilical Cord Mesenchymal Stem Cells
Sponsor:   Shanghai East Hospital
Not yet recruiting
Posted: Tuesday, January 4, 2022 - 12:00
Condition:   Ulcerative Colitis
Intervention:   Drug: ExoFlo
Sponsor:   Direct Biologics, LLC
Not yet recruiting
Posted: Tuesday, November 30, 2021 - 12:00
Conditions:   Neonatal Necrotizing Enterocolitis;   Growth and Development;   Preterm Infants;   Nutrition
Interventions:   Other: Autologous Umbilical Cord Blood Mononuclear Cells Therapy;   Drug: 0.9% Sodium Chloride
Sponsor:   Guangdong Women and Children Hospital
Posted: Tuesday, November 23, 2021 - 12:00
Conditions:   Crohn Disease;   IBS - Irritable Bowel Syndrome
Intervention:   Drug: Bone Marrow MSC Derived Extracellular Vesicle Isolate
Sponsor:   Direct Biologics, LLC
Not yet recruiting